BPC-157, a engineered peptide first developed to manage gastrointestinal injuries in animals, has sparked considerable interest within the health community. Researchers believe it possesses remarkable potential to promote tissue restoration , reduce inflammation , and even accelerate wound recovery . While studies on humans remain restricted,